(Q40501773)

21 September 2017

Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study (English)

1 reference

21 September 2017

2

Grace Lai-Hung Wong

1 reference

21 September 2017

Vincent Wai-Sun Wong

1

1 reference

21 September 2017

Judy Ching-Lam Yeung

3

1 reference

21 September 2017

Chloe Yuk-Kiu Fung

4

1 reference

21 September 2017

Jasmine Ka-Lei Chan

5

1 reference

21 September 2017

Zoe Hoi-Yi Chang

6

1 reference

21 September 2017

Chelsia Tsz-Yan Kwan

7

1 reference

21 September 2017

Hiu-Wan Lam

8

1 reference

21 September 2017

Jenny Limquiaco

9

1 reference

21 September 2017

Angel Mei-Ling Chim

10

1 reference

21 September 2017

Cheuk-Man Yu

11

1 reference

21 September 2017

Henry Lik-Yuen Chan

12

1 reference

21 September 2017

language of work or name

English

0 references

publication date

25 September 2015

1 reference

21 September 2017

1 reference

21 September 2017

63

1 reference

21 September 2017

3

1 reference

21 September 2017

754-763

1 reference

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 September 2017

1 reference

Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.

21 January 2018

1 reference

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

21 January 2018

1 reference

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

21 January 2018

1 reference

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

21 January 2018

1 reference

Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study

21 January 2018

1 reference

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors

21 January 2018

1 reference

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Societ

21 January 2018

1 reference

World Health Organization definition of myocardial infarction: 2008-09 revision

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study

21 January 2018

1 reference

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study

21 January 2018

1 reference

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

A position statement on NAFLD/NASH based on the EASL 2009 special conference

21 January 2018

1 reference

7 January 2021

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

1 reference

7 January 2021

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

7 January 2021

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

7 January 2021

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

7 January 2021

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

7 January 2021

Liver stiffness is directly influenced by central venous pressure

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28253

1 reference

21 September 2017

1 reference